240
Participants
Start Date
May 31, 2024
Primary Completion Date
December 30, 2026
Study Completion Date
June 30, 2027
Chidamide
Induction Therapy
Venetoclax
Induction Therapy
azacitidine
Induction Therapy
Anthracyclines or anthraquinones
Induction Therapy
cytarabine
Induction Therapy
Guangdong Provincial People's Hospital, Guangzhou
Dongguan General Hosptial, Dongguan
Foshan First People's Hospital, Foshan
Sun Yat-sen University Cancer Center, Guangzhou
The Fifth Affiliated Hospital of Guangzhou Medical University, Guangzhou
The First Affiliated Hospital of Guangdong Pharmaceutical University, Guangzhou
The First Affiliated Hospital of Guangzhou Medical University, Guangzhou
The First Affiliated Hospital of Jinan University, Guangzhou
The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou
Shenzhen second people's Hospital, Shenzhen
Affiliated Hospital of Guangdong Medical University, Zhanjiang
Zhuhai General Hosptial, Zhuhai
Hainan General Hosptial, Haikou
Guangdong Provincial People's Hospital
OTHER